142 related articles for article (PubMed ID: 15323564)
1. Selective Itk inhibitors block T-cell activation and murine lung inflammation.
Lin TA; McIntyre KW; Das J; Liu C; O'Day KD; Penhallow B; Hung CY; Whitney GS; Shuster DJ; Yang X; Townsend R; Postelnek J; Spergel SH; Lin J; Moquin RV; Furch JA; Kamath AV; Zhang H; Marathe PH; Perez-Villar JJ; Doweyko A; Killar L; Dodd JH; Barrish JC; Wityak J; Kanner SB
Biochemistry; 2004 Aug; 43(34):11056-62. PubMed ID: 15323564
[TBL] [Abstract][Full Text] [Related]
2. Itk, a T cell-specific tyrosine kinase, is required for CD2-mediated interleukin-2 promoter activation in the human T cell line Jurkat.
Tanaka N; Abe H; Yagita H; Okumura K; Nakamura M; Sugamura K
Eur J Immunol; 1997 Apr; 27(4):834-41. PubMed ID: 9130632
[TBL] [Abstract][Full Text] [Related]
3. Discovery and SAR of 2-amino-5-(thioaryl)thiazoles as potent and selective Itk inhibitors.
Das J; Furch JA; Liu C; Moquin RV; Lin J; Spergel SH; McIntyre KW; Shuster DJ; O'Day KD; Penhallow B; Hung CY; Doweyko AM; Kamath A; Zhang H; Marathe P; Kanner SB; Lin TA; Dodd JH; Barrish JC; Wityak J
Bioorg Med Chem Lett; 2006 Jul; 16(14):3706-12. PubMed ID: 16682193
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of human T cell activation by novel Src kinase inhibitors is dependent upon the complexity of the signal delivered to the cell.
Rapecki S; Allen R
J Pharmacol Exp Ther; 2002 Dec; 303(3):1325-33. PubMed ID: 12438558
[TBL] [Abstract][Full Text] [Related]
5. Discovery and SAR of 2-amino-5-[(thiomethyl)aryl]thiazoles as potent and selective Itk inhibitors.
Das J; Liu C; Moquin RV; Lin J; Furch JA; Spergel SH; Doweyko AM; McIntyre KW; Shuster DJ; O'Day KD; Penhallow B; Hung CY; Kanner SB; Lin TA; Dodd JH; Barrish JC; Wityak J
Bioorg Med Chem Lett; 2006 May; 16(9):2411-5. PubMed ID: 16481166
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the IL-2-inducible tyrosine kinase (Itk) activity: a new concept for the therapy of inflammatory skin diseases.
von Bonin A; Rausch A; Mengel A; Hitchcock M; Krüger M; von Ahsen O; Merz C; Röse L; Stock C; Martin SF; Leder G; Döcke WD; Asadullah K; Zügel U
Exp Dermatol; 2011 Jan; 20(1):41-7. PubMed ID: 21158938
[TBL] [Abstract][Full Text] [Related]
7. The EMT/ITK/TSK (EMT) tyrosine kinase is activated during TCR signaling: LCK is required for optimal activation of EMT.
Gibson S; August A; Kawakami Y; Kawakami T; Dupont B; Mills GB
J Immunol; 1996 Apr; 156(8):2716-22. PubMed ID: 8609388
[TBL] [Abstract][Full Text] [Related]
8. Tec protein tyrosine kinase inhibits CD25 expression in human T-lymphocyte.
Susaki K; Kitanaka A; Dobashi H; Kubota Y; Kittaka K; Kameda T; Yamaoka G; Mano H; Mihara K; Ishida T
Immunol Lett; 2010 Jan; 127(2):135-42. PubMed ID: 19883687
[TBL] [Abstract][Full Text] [Related]
9. Ability of a nondepleting anti-CD4 antibody to inhibit Th2 responses and allergic lung inflammation is independent of coreceptor function.
Li L; Crowley M; Nguyen A; Lo D
J Immunol; 1999 Dec; 163(12):6557-66. PubMed ID: 10586049
[TBL] [Abstract][Full Text] [Related]
10. Activation of type I protein kinase A during receptor-mediated human T lymphocyte activation.
Laxminarayana D; Kammer GM
J Immunol; 1996 Jan; 156(2):497-506. PubMed ID: 8543799
[TBL] [Abstract][Full Text] [Related]
11. Suppressive effect of a novel water-soluble artemisinin derivative SM905 on T cell activation and proliferation in vitro and in vivo.
Wang JX; Tang W; Yang ZS; Wan J; Shi LP; Zhang Y; Zhou R; Ni J; Hou LF; Zhou Y; He PL; Yang YF; Li Y; Zuo JP
Eur J Pharmacol; 2007 Jun; 564(1-3):211-8. PubMed ID: 17349993
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of p56(lck) tyrosine kinase by isothiazolones.
Trevillyan JM; Chiou XG; Ballaron SJ; Tang QM; Buko A; Sheets MP; Smith ML; Putman CB; Wiedeman P; Tu N; Madar D; Smith HT; Gubbins EJ; Warrior UP; Chen YW; Mollison KW; Faltynek CR; Djurić SW
Arch Biochem Biophys; 1999 Apr; 364(1):19-29. PubMed ID: 10087161
[TBL] [Abstract][Full Text] [Related]
13. The Src-homology domain 2-bearing protein tyrosine phosphatase-1 inhibits antigen receptor-induced apoptosis of activated peripheral T cells.
Zhang J; Somani AK; Watt S; Mills GB; Siminovitch KA
J Immunol; 1999 Jun; 162(11):6359-67. PubMed ID: 10352248
[TBL] [Abstract][Full Text] [Related]
14. Cell permeable NFAT inhibitory peptide Sim-2-VIVIT inhibits T-cell activation and alleviates allergic airway inflammation and hyper-responsiveness.
Choi JM; Sohn JH; Park TY; Park JW; Lee SK
Immunol Lett; 2012 Apr; 143(2):170-6. PubMed ID: 22342853
[TBL] [Abstract][Full Text] [Related]
15. Bromelain, from pineapple stems, proteolytically blocks activation of extracellular regulated kinase-2 in T cells.
Mynott TL; Ladhams A; Scarmato P; Engwerda CR
J Immunol; 1999 Sep; 163(5):2568-75. PubMed ID: 10452995
[TBL] [Abstract][Full Text] [Related]
16. Induction of lysosomal and plasma membrane-bound sialidases in human T-cells via T-cell receptor.
Wang P; Zhang J; Bian H; Wu P; Kuvelkar R; Kung TT; Crawley Y; Egan RW; Billah MM
Biochem J; 2004 Jun; 380(Pt 2):425-33. PubMed ID: 14992689
[TBL] [Abstract][Full Text] [Related]
17. SLP-76 mediates and maintains activation of the Tec family kinase ITK via the T cell antigen receptor-induced association between SLP-76 and ITK.
Bogin Y; Ainey C; Beach D; Yablonski D
Proc Natl Acad Sci U S A; 2007 Apr; 104(16):6638-43. PubMed ID: 17420479
[TBL] [Abstract][Full Text] [Related]
18. Positive feedback regulation of PLCgamma1/Ca(2+) signaling by PKCtheta in restimulated T cells via a Tec kinase-dependent pathway.
Altman A; Kaminski S; Busuttil V; Droin N; Hu J; Tadevosyan Y; Hipskind RA; Villalba M
Eur J Immunol; 2004 Jul; 34(7):2001-11. PubMed ID: 15214048
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the kinase ITK in a mouse model of asthma reduces cell death and fails to inhibit the inflammatory response.
Sun Y; Peng I; Webster JD; Suto E; Lesch J; Wu X; Senger K; Francis G; Barrett K; Collier JL; Burch JD; Zhou M; Chen Y; Chan C; Eastham-Anderson J; Ngu H; Li O; Staton T; Havnar C; Jaochico A; Jackman J; Jeet S; Riol-Blanco L; Wu LC; Choy DF; Arron JR; McKenzie BS; Ghilardi N; Ismaili MH; Pei Z; DeVoss J; Austin CD; Lee WP; Zarrin AA
Sci Signal; 2015 Dec; 8(405):ra122. PubMed ID: 26628680
[TBL] [Abstract][Full Text] [Related]
20. Discovery of aminoquinazolines as potent, orally bioavailable inhibitors of Lck: synthesis, SAR, and in vivo anti-inflammatory activity.
DiMauro EF; Newcomb J; Nunes JJ; Bemis JE; Boucher C; Buchanan JL; Buckner WH; Cee VJ; Chai L; Deak HL; Epstein LF; Faust T; Gallant P; Geuns-Meyer SD; Gore A; Gu Y; Henkle B; Hodous BL; Hsieh F; Huang X; Kim JL; Lee JH; Martin MW; Masse CE; McGowan DC; Metz D; Mohn D; Morgenstern KA; Oliveira-dos-Santos A; Patel VF; Powers D; Rose PE; Schneider S; Tomlinson SA; Tudor YY; Turci SM; Welcher AA; White RD; Zhao H; Zhu L; Zhu X
J Med Chem; 2006 Sep; 49(19):5671-86. PubMed ID: 16970394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
